ArticleMedicine2025
HBOT-induced noncardiogenic pulmonary edema in acute carbon monoxide poisoning: A case report and mechanistic insights.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
rationaleAcute carbon monoxide poisoning is a common medical emergency, and hyperbaric oxygen therapy (HBOT) serves as the cornerstone of treatment. Although rare, serious complications such as acute pulmonary edema (APE) can be life-threatening. Most reported cases involve patients with preexisting cardiac conditions, making this case of APE in a patient without cardiac comorbidities particularly noteworthy. PATIENT CONCERNS: A 35-year-old male patient developed dyspnea accompanied by severe coughing during the decompression phase of HBOT for acute carbon monoxide poisoning. DIAGNOSES: Emergency chest computed tomography showed APE.
interventionsImmediate endotracheal intubation and mechanical ventilation were initiated, along with a combination of diuretics, glucocorticoids, and bronchodilators. OUTCOMES: During the 3-month follow-up period, the patient remained asymptomatic with complete resolution of clinical manifestations. LESSONS: Although HBOT-induced APE is a rare complication, its critical clinical implications necessitate rigorous monitoring of respiratory dynamics and oxygenation status during treatment sessions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.